<info type="GeneOrGeneProduct">Serotonin 6 receptor gene</info> is associated with <info type="DiseaseOrPhenotypicFeature">methamphetamine-induced psychosis</info> in a <info type="OrganismTaxon">Japanese</info> population.

BACKGROUND: Altered <info type="GeneOrGeneProduct">serotonergic</info> neural transmission is hypothesized to be a susceptibility factor for <info type="DiseaseOrPhenotypicFeature">psychotic disorders</info> such as <info type="DiseaseOrPhenotypicFeature">schizophrenia</info>. The <info type="GeneOrGeneProduct">serotonin 6</info> (<info type="GeneOrGeneProduct">5-HT6</info>) receptor is therapeutically targeted by several <info type="ChemicalEntity">second generation antipsychotics</info>, such as <info type="ChemicalEntity">clozapine</info> and <info type="ChemicalEntity">olanzapine</info>, and <info type="ChemicalEntity">d-amphetamine</info>-induced <info type="DiseaseOrPhenotypicFeature">hyperactivity</info> in <info type="OrganismTaxon">rats</info> is corrected with the use of a selective <info type="GeneOrGeneProduct">5-HT6 receptor antagonist</info>. In addition, the disrupted <info type="DiseaseOrPhenotypicFeature">prepulse inhibition</info> induced by <info type="ChemicalEntity">d-amphetamine</info> or <info type="ChemicalEntity">phencyclidine</info> was restored by <info type="GeneOrGeneProduct">5-HT6 receptor antagonist</info> in an animal study using <info type="OrganismTaxon">rats</info>. These animal models were considered to reflect the positive symptoms of <info type="DiseaseOrPhenotypicFeature">schizophrenia</info>, and the above evidence suggests that altered <info type="GeneOrGeneProduct">5-HT6 receptors</info> are involved in the pathophysiology of <info type="DiseaseOrPhenotypicFeature">psychotic disorders</info>. The symptoms of <info type="DiseaseOrPhenotypicFeature">methamphetamine (METH)-induced psychosis</info> are similar to those of <info type="DiseaseOrPhenotypicFeature">paranoid type schizophrenia</info>. Therefore, we conducted an analysis of the association of the <info type="GeneOrGeneProduct">5-HT6 gene</info> (<info type="GeneOrGeneProduct">HTR6</info>) with <info type="DiseaseOrPhenotypicFeature">METH-induced psychosis</info>. METHOD: Using five tagging <info type="SequenceVariant">SNPs</info> (<info type="SequenceVariant">rs6693503</info>, <info type="SequenceVariant">rs1805054</info>, <info type="SequenceVariant">rs4912138</info>, <info type="SequenceVariant">rs3790757</info> and <info type="SequenceVariant">rs9659997</info>), we conducted a genetic association analysis of case-control samples (<info type="DiseaseOrPhenotypicFeature">197 METH-induced psychosis patients</info> and <info type="DiseaseOrPhenotypicFeature">337 controls</info>) in the <info type="OrganismTaxon">Japanese</info> population. The age and sex of the control subjects did not differ from those of the <info type="DiseaseOrPhenotypicFeature">methamphetamine dependence patients</info>. RESULTS: <info type="SequenceVariant">rs6693503</info> was associated with <info type="DiseaseOrPhenotypicFeature">METH-induced psychosis patients</info> in the allele/genotype-wise analysis. Moreover, this association remained significant after <info type="ChemicalEntity">Bonferroni correction</info>. In the haplotype-wise analysis, we detected an association between two markers (<info type="SequenceVariant">rs6693503</info> and <info type="SequenceVariant">rs1805054</info>) and three markers (<info type="SequenceVariant">rs6693503</info>, <info type="SequenceVariant">rs1805054</info> and <info type="SequenceVariant">rs4912138</info>) in <info type="GeneOrGeneProduct">HTR6</info> and <info type="DiseaseOrPhenotypicFeature">METH-induced psychosis patients</info>, respectively. CONCLUSION: <info type="GeneOrGeneProduct">HTR6</info> may play an important role in the pathophysiology of <info type="DiseaseOrPhenotypicFeature">METH-induced psychosis</info> in the <info type="OrganismTaxon">Japanese</info> population.